Personal reflection on declining review requests for papers in non-open-access journals, suggesting the implications for academic publishing.
This morning, I was invited to review a paper — one very relevant to my interests — for a non-open-access journal owned by one of the large commercial barrier-based publishers. This has happened to me several times now; and I declined, as I have done ever since 2011. I know this path is not for everyone.
No takes yet. Share an insight, caveat, or question.
Mike Taylor (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: